Sheng‐Long Ye

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2020 · 833 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +13

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2023 · 452 citations · Full text

Medicine, Oncology, Cancer Control +12

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma

Xin‐Da Zhou, Zhao–You Tang, Bing‐Hui Yang et al. · Cancer · 2001 · 302 citations

Medicine, Oncology, Surgery +14

<scp>GIDEON</scp> (Global Investigation of therapeutic <scp>DE</scp> cisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

Riccardo Lencioni, Masatoshi Kudo, Sheng‐Long Ye et al. · International Journal of Clinical Practice · 2013 · 222 citations

Medicine, Oncology, Pharmacotherapy +17